Article
A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).
BMC cancer - 3 Jul 2017
Zhou Qing, Song Yong, Zhang Xin, Chen Gong-Yan, Zhong Dian-Sheng, Yu Zhuang, Yu Ping, Zhang Yi-Ping, Chen Jian-Hua, Hu Yi, Feng Guo-Sheng, Song Xia, Shi Qiang, Yang Lu Lu, Zhang Ping Hai, Wu Yi-Long
Abstract excerpt
BACKGROUND: In recent years, systemic chemotherapy and molecular targeted therapy have become standard first-line treatments for locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC). The objective of this survey was to investigate first-line anticancer treatment patterns and gene aberration test status of patients with advanced nonsquamous NSCLC in China. METHODS: Patients included in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.